Immuno-Oncology 360° addresses business aspects, clinical advancements and scientific data for cancer immunotherapy that helps advance technology platforms to develop therapeutics at an accelerated rate. The rapid advancement in our understanding of human cancer immunity and immunotherapy combinations is nearly impossible for individual scientists to comprehend. Only together, as an engaged and interactive scientific community, can we hope to enable a patient’s immune system to eradicate cancer.
Immuno-Oncology 360° provides 10 plenary sessions over the course of 3 days addressing:
Discovery / Preclinical Science
Translational Science & Biomarkers
Clinical Data Developments
Clinical Operations
Imaging Aspects
Cell Therapy
Emerging Technologies
Business Aspects
Financial & Commercial Implications
Trends in the Field
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us